2022 - Research.com Best Female Scientist Award
Type 2 diabetes, Diabetes mellitus, Internal medicine, Endocrinology and Randomized controlled trial are her primary areas of study. Her Type 2 diabetes research incorporates elements of Meta-analysis, Incidence and Weight loss. Her Diabetes mellitus study integrates concerns from other disciplines, such as Physical therapy, Surgery, Gerontology and MEDLINE.
Her study explores the link between Internal medicine and topics such as Placebo that cross with problems in Dapagliflozin and Adverse effect. Melanie J. Davies usually deals with Randomized controlled trial and limits it to topics linked to Quality of life and Depression. Her work in Type 2 Diabetes Mellitus covers topics such as Disease which are related to areas like Kidney disease and Intensive care medicine.
The scientist’s investigation covers issues in Type 2 diabetes, Internal medicine, Diabetes mellitus, Endocrinology and Randomized controlled trial. Her Type 2 diabetes research includes elements of Metformin, Gerontology, Meta-analysis, Physical therapy and Type 2 Diabetes Mellitus. Her Physical therapy research integrates issues from Intervention and Sitting.
Her Internal medicine study frequently links to other fields, such as Placebo. Her Diabetes mellitus research is multidisciplinary, incorporating perspectives in Surgery, Disease, MEDLINE and Intensive care medicine. Her studies in Body mass index integrate themes in fields like Demography and Obesity.
Her main research concerns Type 2 diabetes, Internal medicine, Diabetes mellitus, Body mass index and Demography. Melanie J. Davies has researched Type 2 diabetes in several fields, including Metformin, MEDLINE, Cohort, Disease and Type 2 Diabetes Mellitus. Her Internal medicine research is multidisciplinary, incorporating perspectives in Placebo, Endocrinology and Semaglutide.
The concepts of her Diabetes mellitus study are interwoven with issues in Insulin, Heart failure, Kidney disease and Intensive care medicine. Her research in Body mass index intersects with topics in Biobank and Confidence interval. Her work carried out in the field of Randomized controlled trial brings together such families of science as Gastroenterology, Physical therapy and Blood pressure.
Her primary scientific interests are in Internal medicine, Type 2 diabetes, Diabetes mellitus, Body mass index and Demography. The various areas that Melanie J. Davies examines in her Type 2 diabetes study include Type 2 Diabetes Mellitus, Disease, MEDLINE and Cardiology. Her Type 2 Diabetes Mellitus research is multidisciplinary, relying on both Clinical trial and Lifestyle management.
The study incorporates disciplines such as Depression, Kidney disease and Intensive care medicine in addition to Diabetes mellitus. Her Body mass index study integrates concerns from other disciplines, such as Biobank, Confidence interval and Environmental health. Melanie J. Davies has researched Demography in several fields, including Odds ratio, Logistic regression, Obesity, Cohort study and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
Diabetes Care (2018)
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis
Emma G Wilmot;Emma G Wilmot;Charlotte L Edwardson;Charlotte L Edwardson;Felix A Achana;Melanie J Davies;Melanie J Davies;Melanie J Davies.
Diabetologia (2012)
The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis
S. Ali;M. A. Stone;J. L. Peters;M. J. Davies.
Diabetic Medicine (2006)
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
Diabetologia (2020)
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes
Kjeld Hermansen;Melanie Davies;Taudeusz Derezinski;Gabrielle Martinez Ravn.
Diabetes Care (2006)
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
Rury R. Holman;Kerensa I. Thorne;Andrew J. Farmer;Melanie J. Davies.
The New England Journal of Medicine (2007)
Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial
Melanie J. Davies;S. Heller;T.C. Skinner;M.J. Campbell.
BMJ (2008)
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis
Patrice Carter;Laura J Gray;Jacqui Troughton;Kamlesh Khunti.
web science (2010)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman;Andrew J. Farmer;Melanie J. Davies;Jonathan C. Levy.
The New England Journal of Medicine (2009)
Effect of valsartan on the incidence of diabetes and cardiovascular events.
John McMurray;R Holman;Steven Haffner;M Bethel.
The New England Journal of Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Leicester
University of Southern Queensland
University of the Highlands and Islands
University of Oxford
University of Cambridge
University of Sheffield
University of Oxford
Baker IDI Heart and Diabetes Institute
University of Cambridge
University of Glasgow
Pontifical Catholic University of Rio de Janeiro
Vassar College
University of Technology Sydney
Imperial College London
Nanyang Technological University
International Institute for Applied Systems Analysis
University of Tokyo
University of Oxford
National Centre for Cell Science
University of Exeter
Centre national de la recherche scientifique, CNRS
Goddard Space Flight Center
Texas Tech University
Cold Spring Harbor Laboratory
University of London
George Mason University